Osteopathy and Latent Hypothyroidism

NCT ID: NCT02430857

Last Updated: 2015-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effectiveness of stimulating the neurological segments c8-th5 in patients with latent hypothyroidism.

One half of the participants will receive an osteopathic manuel treatment in order to stimulate the relevant segments, the other half will receive no treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with latent hypothyroidism show an increased hormone status in TSH and a normal hormone status in fT4. A study has shown that osteopathic treatment had positive effects to some symptoms in patients with latent hypothyroidism. The study was using the pain inventory as the instrument to measure the effect. In this study we want to evaluate the effectiveness of the treatment on the hormone status (TSH, fT4) The intervention group will receive a neurological osteopathic stimulation over 5 weeks. A parallel control group will not receive any therapy.

A follow up blood screening (TSH, fT4) will be done. The results of both groups will be compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Latent Hypothyroidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OMT-Group

The OMT-group will get an osteopathic treatment once a week for 1 hour for 5 weeks. The blood will be screened again after the treatment.

Group Type EXPERIMENTAL

OMT

Intervention Type OTHER

Manuel osteopathic treatment of the spine

Controll Group

This group will receive no treatment. A blood screening is made again after 5 weeks.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OMT

Manuel osteopathic treatment of the spine

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* latent hypothyroidism

Exclusion Criteria

* Factors that Alter Thyroxine and Triiodothyronine Binding in Serum
* Increased thyroxin-binding globulin
* Decreased thyroxin-binding globulin
* Binding inhibitors
* Inherited Salicylates
* Pregnancy
* Androgens
* Furosemide
* Neonatal state
* Anabolic steroids
* Free fatty acids
* Estrogens
* Glucocorticoids
* Phenytoin
* Hepatitis
* Severe illness
* Carbamazepine
* Porphyria
* Hepatic failure
* nonsteroidal antiinflammatory drug (variable, transient)
* Heroin
* Nephrosis
* Heparin
* Methadone
* Nicotinic acid
* Mitotane L-Asparaginase
* 5-Fluorouracil
* SERMS (e.g., tamoxifen, raloxifene)
* Perphenazine
* spinal pathologies
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emanuel Amier Diekmann

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emanuel Amier Diekmann

DO

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emanuel Diekmann, DO

Role: PRINCIPAL_INVESTIGATOR

Praxis fuer Osteopathy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emanuel Diekmann, DO

Role: CONTACT

0041788800341

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-5-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Subclinical Hypothyroidism and Mind in the Elderly
NCT00921050 COMPLETED PHASE2/PHASE3
Recurrent Pregnancy Loss and Thyroid Disease
NCT03106935 UNKNOWN EARLY_PHASE1
Thyroxine Titration Study
NCT00111735 UNKNOWN PHASE4